Cambridge Nutritional Sciences – interims, how significant the previously-argued “progress and achievement” now?
Most recently on company describing itself as a “specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition” Cambridge Nutritional Sciences (CNSL), on August-announced full year results with the shares down to 3.3p I questioned how significant financially its emphasised “significant progress and achievement” and concluded to still avoid. What about now results for its half-year ended 30th September 2025 headlined “Company remains EBITDA positive with further improvements in gross margin. Sales and marketing teams restructured to deliver long term growth”… and the shares currently at 2.25p in response, a further more than 15% down?
